Patient and provider barriers to effective management of gout in general practice: a qualitative study: Figure 1

Spencer, Karen; Carr, Alison; Doherty, Michael

doi:10.1136/annrheumdis-2011-200801

Cited by 187 publications

(179 citation statements)

References 34 publications

Supporting

Mentioning

156

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, the predominantly male patients may feel that they have to appear 'manly' and bear with the symptoms. (14) Adherence rates to pharmacotherapy in gout are particularly poor, ranging from 18%-44%, and significantly lower than those in patients with other chronic diseases. (15,16) Reasons offered by patients who were nonadherent include the belief that they were cured, fear of side effects and pill burden; (14) this is especially relevant in the local context as most formulations of allopurinol are only available in 100-mg tablets.…”

Section: Patient Factorsmentioning

confidence: 99%

“…Studies among health professionals have shown that many perceive gout as an acute disease and presume that patients would prefer to take painkillers when necessary rather than be on long-term medication. (14) In a healthcare system such as Singapore's where patients tend to visit a variety of doctors and hospitals, there may be inertia to start a new drug unless the patient sees the same doctor who can appreciate their recurrent attacks.…”

Section: Physician Factorsmentioning

confidence: 99%

See 1 more Smart Citation

Poorly controlled gout: who is doing poorly?

Chia¹

2016

smedj

View full text Add to dashboard Cite

Gout, an inflammatory arthritis caused by the deposition of monosodium urate crystals, is commonly seen in primary care and specialist clinics. In recent years, there has been a resurgence of interest in gout due to advances in therapies and the understanding of pathophysiology, with new guidelines being published by international bodies. However, there is still a gap between the goals of treatment and actual day-to-day practice. Barriers that result in poorly controlled gout include patient factors such as lack of understanding of the disease, stigma and nonadherence to treatment, as well as physician factors such as knowledge gaps, inadequate use of allopurinol and lack of ownership of the disease. The medical profession needs to do more to bridge the gap through physician and patient education, identification of treatment targets with appropriate use of drugs, and dissemination of guidelines.

show abstract

Section: Patient Factorsmentioning

confidence: 99%

Section: Physician Factorsmentioning

confidence: 99%

Poorly controlled gout: who is doing poorly?

Chia¹

2016

smedj

View full text Add to dashboard Cite

show abstract

“…36,37 It is no longer appropriate to consider gout as the 'disease of the affluent' or that it is solely related to overindulgence. …”

Section: Resultsmentioning

confidence: 99%

Current treatment options for acute and chronic gout

Jordan¹,

Jeffries²

2014

Prescriber

View full text Add to dashboard Cite

show abstract

“…Highly effective uric acid-lowering therapies (ULTs) are available, however, adherence to ULTs in gout patients is among the lowest of all chronic diseases [11]. Poor quality educational resources and limited patient knowledge have been identified as key barriers to adequate ULT adherence [12,13]. Delivery of an intervention by nurses comprising of personalised education, lifestyle advice and appropriate prescribing of ULTs resulted in 92% of patients achieving target SUA concentrations oneyear post-intervention [14].…”

Section: Introductionmentioning

confidence: 99%